Is Pulmonx Corp Stock a Good Investment?
Pulmonx Corp Investment Advice | LUNG |
- Examine Pulmonx Corp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Pulmonx Corp's leadership team and their track record. Good management can help Pulmonx Corp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Pulmonx Corp's business and its evolving consumer preferences.
- Compare Pulmonx Corp's performance and market position to its competitors. Analyze how Pulmonx Corp is positioned in terms of product offerings, innovation, and market share.
- Check if Pulmonx Corp pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Pulmonx Corp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Pulmonx Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Pulmonx Corp is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Pulmonx Corp Stock
Researching Pulmonx Corp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 95.0% of the company shares are owned by institutional investors. The book value of Pulmonx Corp was now reported as 2.38. The company recorded a loss per share of 1.47. Pulmonx Corp had not issued any dividends in recent years.
To determine if Pulmonx Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Pulmonx Corp's research are outlined below:
| Pulmonx Corp had very high historical volatility over the last 90 days | |
| Pulmonx Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 68.67 M. Net Loss for the year was (60.84 M) with profit before overhead, payroll, taxes, and interest of 39.87 M. | |
| Pulmonx Corp currently holds about 162.09 M in cash with (37.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.35. | |
| Pulmonx Corp has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Insider Selling Pulmonx Co. Director Sells 20,000 Shares of Stock |
Pulmonx Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Pulmonx Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pulmonx Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Pulmonx Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Pulmonx Corp's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-05-04 | 2021-03-31 | -0.38 | -0.34 | 0.04 | 10 | ||
2024-02-21 | 2023-12-31 | -0.41 | -0.36 | 0.05 | 12 | ||
2022-05-03 | 2022-03-31 | -0.37 | -0.43 | -0.06 | 16 | ||
2024-07-31 | 2024-06-30 | -0.43 | -0.35 | 0.08 | 18 | ||
2024-10-30 | 2024-09-30 | -0.45 | -0.36 | 0.09 | 20 | ||
2021-11-02 | 2021-09-30 | -0.37 | -0.28 | 0.09 | 24 | ||
2024-05-01 | 2024-03-31 | -0.46 | -0.36 | 0.1 | 21 | ||
2020-11-10 | 2020-09-30 | -4.32 | -1.37 | 2.95 | 68 |
Know Pulmonx Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Pulmonx Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pulmonx Corp backward and forwards among themselves. Pulmonx Corp's institutional investor refers to the entity that pools money to purchase Pulmonx Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Franklin Resources Inc | 2024-09-30 | 700.4 K | Rock Springs Capital Management Lp | 2024-06-30 | 652.4 K | Pura Vida Investments, Llc | 2024-09-30 | 509.8 K | Altium Capital Management, Lp | 2024-09-30 | 500 K | Millennium Management Llc | 2024-06-30 | 448.6 K | Partner Fund Management Lp | 2024-09-30 | 368.9 K | Northern Trust Corp | 2024-09-30 | 362.2 K | D. E. Shaw & Co Lp | 2024-09-30 | 360.8 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 347.5 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 6.9 M | Fmr Inc | 2024-09-30 | 5.9 M |
Pulmonx Corp's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 254.7 M.Market Cap |
|
Pulmonx Corp's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.35) | (0.36) | |
| Return On Capital Employed | (0.40) | (0.42) | |
| Return On Assets | (0.34) | (0.36) | |
| Return On Equity | (0.51) | (0.49) |
Determining Pulmonx Corp's profitability involves analyzing its financial statements and using various financial metrics to determine if Pulmonx Corp is a good buy. For example, gross profit margin measures Pulmonx Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Pulmonx Corp's profitability and make more informed investment decisions.
Pulmonx Corp's Earnings Breakdown by Geography
Evaluate Pulmonx Corp's management efficiency
Pulmonx Corp has return on total asset (ROA) of (0.2004) % which means that it has lost $0.2004 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5199) %, meaning that it created substantial loss on money invested by shareholders. Pulmonx Corp's management efficiency ratios could be used to measure how well Pulmonx Corp manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.36. The current Return On Capital Employed is estimated to decrease to -0.42. At this time, Pulmonx Corp's Asset Turnover is most likely to slightly decrease in the upcoming years.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.12 | 3.27 | |
| Tangible Book Value Per Share | 3.05 | 3.21 | |
| Enterprise Value Over EBITDA | (8.02) | (8.43) | |
| Price Book Value Ratio | 4.09 | 4.30 | |
| Enterprise Value Multiple | (8.02) | (8.43) | |
| Price Fair Value | 4.09 | 4.30 | |
| Enterprise Value | 442.1 M | 420 M |
Leadership effectiveness at Pulmonx Corp is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta 0.684 |
Basic technical analysis of Pulmonx Stock
As of the 1st of December, Pulmonx Corp holds the Risk Adjusted Performance of (0.01), variance of 19.05, and Coefficient Of Variation of (3,444). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulmonx Corp, as well as the relationship between them. Please check Pulmonx Corp variance and potential upside to decide if Pulmonx Corp is priced some-what accurately, providing market reflects its current price of 6.45 per share. Given that Pulmonx Corp has information ratio of (0.06), we recommend you to check out Pulmonx Corp's recent market performance to make sure the company can sustain itself at a future point.Pulmonx Corp's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pulmonx Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pulmonx Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pulmonx Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pulmonx Corp's Outstanding Corporate Bonds
Pulmonx Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pulmonx Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pulmonx bonds can be classified according to their maturity, which is the date when Pulmonx Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| PulteGroup 6 percent Corp BondUS745867AT82 | View | |
| PulteGroup 55 percent Corp BondUS745867AW12 | View | |
| PulteGroup 5 percent Corp BondUS745867AX94 | View | |
| PulteGroup 7875 percent Corp BondUS745867AM30 | View | |
| PulteGroup 6375 percent Corp BondUS745867AP60 | View |
Understand Pulmonx Corp's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Pulmonx Corp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 3.18 | |||
| Coefficient Of Variation | (3,444) | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.05 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 20.44 | |||
| Value At Risk | (6.89) | |||
| Potential Upside | 8.44 | |||
| Skewness | 0.3052 | |||
| Kurtosis | 1.22 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 3.18 | |||
| Coefficient Of Variation | (3,444) | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.05 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 20.44 | |||
| Value At Risk | (6.89) | |||
| Potential Upside | 8.44 | |||
| Skewness | 0.3052 | |||
| Kurtosis | 1.22 |
Consider Pulmonx Corp's intraday indicators
Pulmonx Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pulmonx Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Pulmonx Corp Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 1st of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 30th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Pulmonx Stock media impact
Far too much social signal, news, headlines, and media speculation about Pulmonx Corp that are available to investors today. That information is available publicly through Pulmonx media outlets and privately through word of mouth or via Pulmonx internal channels. However, regardless of the origin, that massive amount of Pulmonx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pulmonx Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulmonx Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulmonx Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulmonx Corp alpha.
Pulmonx Corp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Pulmonx Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Pulmonx Corp Corporate Management
| David Lehman | General Secretary | Profile | |
| Geoffrey Rose | Chief Officer | Profile | |
| Lauren Cristina | VP Adm | Profile | |
| John McKune | VP Controller | Profile | |
| Sri Radhakrishnan | Chief Officer | Profile | |
| Mehul Joshi | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.154 | Return On Assets (0.20) | Return On Equity (0.52) |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Pulmonx Corp's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.